BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang CY, Liu S, Yang M. Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy. World J Gastroenterol 2022; 28(27): 3346-3358 [PMID: 36158267 DOI: 10.3748/wjg.v28.i27.3346]
URL: https://www.wjgnet.com/1007-9327/full/v28/i27/3346.htm
Number Citing Articles
1
Zachary J. Brown, Samantha M. Ruff, Timothy M. Pawlik. The effect of liver disease on hepatic microenvironment and implications for immune therapyFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1225821
2
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. In vitro and in vivo experimental models for cancer immunotherapy studyCurrent Research in Biotechnology 2024; 7: 100210 doi: 10.1016/j.crbiot.2024.100210
3
Pietro Guerra, Andrea Martini, Patrizia Pontisso, Paolo Angeli. Novel Molecular Targets for Immune Surveillance of Hepatocellular CarcinomaCancers 2023; 15(14): 3629 doi: 10.3390/cancers15143629
4
Kah Ming Wong, Yong Hui Wong, Sau Har Lee. In Silico Discovery of LL13, a Shortened Pardaxin 6 Peptide Derivative with Anti-proliferative ActivityInternational Journal of Peptide Research and Therapeutics 2024; 30(4) doi: 10.1007/s10989-024-10615-9
5
Lien-Hung Huang, Cheng-Shyuan Rau, Yueh-Wei Liu, Chia-Jung Wu, Peng-Chen Chien, Hui-Ping Lin, Yi-Chan Wu, Chun-Ying Huang, Ting-Min Hsieh, Ching-Hua Hsieh. Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4+ T Cells of Hepatocellular Carcinoma PatientsBiomedicines 2023; 11(7): 1848 doi: 10.3390/biomedicines11071848
6
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitisExploration of Digestive Diseases 2023; : 246 doi: 10.37349/edd.2023.00029
7
Gaocheng Wang, Jingjing Wang, Shuilin Dong, Zhanguo Zhang, Wanguang Zhang, Jianping Zhao. Immune checkpoint inhibitor‑associated diabetes mellitus in patients with HCC: Report of three cases and literature reviewExperimental and Therapeutic Medicine 2024; 27(5) doi: 10.3892/etm.2024.12486
8
Ming Yang, Ethan Vanderwert, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li. The Important Roles of Natural Killer Cells in Liver FibrosisBiomedicines 2023; 11(5): 1391 doi: 10.3390/biomedicines11051391
9
Zhanao He, Jie Zhang, Wukui Huang. Diagnostic role and immune correlates of programmed cell death-related genes in hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47560-4
10
Chun-Ye Zhang, Shuai Liu, Ming Yang. Treatment of liver fibrosis: Past, current, and futureWorld Journal of Hepatology 2023; 15(6): 755-774 doi: 10.4254/wjh.v15.i6.755
11
Xinyan Wu, Zhigang Zhou, Qiang Cao, Yuquan Chen, Junling Gong, Qi Zhang, Yi Qiang, Yanfeng Lu, Guangzhu Cao. Reprogramming of Treg cells in the inflammatory microenvironment during immunotherapy: a literature reviewFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1268188
12
Mona Abd El-Rahman Abu El-Makarem, Douaa Mohammed Sayed, Ragaa Abdelshaheed Matta, Mahmoud Ragab Mohamed, Manal Ameer Abd El-Malak, Nehal Ibrahim Abbas. Interaction of peripheral CD4+CD25+CD127− Tregs with prolactin in HCV hepatocellular carcinoma: oncogenic or immunogenic mechanismsEgyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00250-2
13
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. The Roles of Myeloid-Derived Suppressor Cells in Liver DiseaseBiomedicines 2024; 12(2): 299 doi: 10.3390/biomedicines12020299